ARTA
PBYI icon

A.R.T. Advisors’s Puma Biotechnology PBYI Stock Holding History

A.R.T. Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-64,993
Closed -$826K – 1660
2019
Q2 		$826K Buy
64,993
+4,100
+7% +$94.4K 0.05% 539
2019
Q1 		$2.36M Buy
60,893
+3,400
+6% +$104K 0.14% 196
2018
Q4 		$1.17M Buy
+57,493
New +$1.73M 0.08% 391
2018
Q3 		– Sell
-24,593
Closed -$1.45M – 1625
2018
Q2 		$1.45M Sell
24,593
-16,800
-41% -$974K 0.06% 471
2018
Q1 		$2.82M Buy
41,393
+7,803
+23% +$584K 0.11% 256
2017
Q4 		$3.32M Buy
+33,590
New +$3.76M 0.15% 195
2017
Q3 		– Sell
-17,594
Closed -$1.54M – 1579
2017
Q2 		$1.54M Buy
+17,594
New +$984K 0.08% 349
2017
Q1 		– Sell
-25,400
Closed -$779K – 1638
2016
Q4 		$779K Buy
25,400
+12,400
+95% +$536K 0.05% 565
2016
Q3 		$871K Buy
+13,000
New +$657K 0.28% 84
2014
Q1 		– Sell
-11,340
Closed -$1.17M – 1500
2013
Q4 		$1.17M Sell
11,340
-15,540
-58% -$912K 0.06% 418
2013
Q3 		$1.44M Buy
26,880
+6,708
+33% +$362K 0.08% 378
2013
Q2 		$895K Buy
+20,172
New +$711K 0.03% 671

Other funds holding PBYI

PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

A.R.T. Advisors's PBYI Position: Q3 2019 in Review

A.R.T. Advisors sold out of Puma Biotechnology (PBYI) in Q3 2019, closing a stake of 64,993 shares — an estimated $826K sold.

A.R.T. Advisors first reported a position in PBYI in Q2 2013 and held it in 12 quarters. The position peaked at $3.32M in Q4 2017. 144 funds tracked by Wall St. Rank hold PBYI as of Q3 2019.

  • A.R.T. Advisors reported no remaining Puma Biotechnology position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 64,993 Puma Biotechnology shares in Q3 2019, an estimated $826K.
  • A.R.T. Advisors first reported a position in Puma Biotechnology in Q2 2013 and held it in 12 quarters.
  • A.R.T. Advisors's Puma Biotechnology position peaked at $3.32M in Q4 2017.
  • 144 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.